Current:Home > reviewsTemple University chancellor to take over leadership amid search for new president -WealthTrack
Temple University chancellor to take over leadership amid search for new president
View
Date:2025-04-14 09:17:44
PHILADELPHIA (AP) — Temple University says former president and current chancellor Richard Englert will take over temporarily as president following the death last week of then-acting president JoAnne Epps.
Englert serve as a “transitional leader” to carry on the work Epps started “and provide a steady hand of leadership while the search for Temple’s next chief executive continues,” the Philadelphia university said in an announcement Tuesday.
From 2016 to 2021, Englert served as Temple president, and earlier stepped in as acting president during a nearly half- century career at the university.
The school said it hopes to announce the choice of the next president in spring 2024.
Epps died a week ago at 72 after falling ill on stage at a memorial event, after which the “acting” designation was removed from her title in recognition of her contributions during her brief tenure. The following day saw an outpouring of affection on the university’s campus where flags were flown at half-staff and dozens gathered to remember her.
Temple’s former law school dean and provost took over in April from Jason Wingard, Temple’s first Black president who had led the 33,600-student university since July 2021. His resignation in March came shortly before a no-confidence vote by the faculty union, with members citing concerns over falling enrollment, financial issues and labor disputes.
Following her predecessor’s tumultuous tenure, Epps had vowed to focus on enrollment as well as safety amid an uptick in crime near the north Philadelphia campus. She told The Philadelphia Inquirer, which reported enrollment was down 14% since 2019, that she believed she was selected in part for her ability to “calm waters.”
veryGood! (94)
Related
- Nevada attorney general revives 2020 fake electors case
- Businessman Who Almost Went on OceanGate Titanic Dive Reveals Alleged Texts With CEO on Safety Concerns
- SEC Proposes Landmark Rule Requiring Companies to Tell Investors of Risks Posed by Climate Change
- Shark Tank’s Barbara Corcoran Reveals Which TV Investment Made Her $468 Million
- The Daily Money: Spending more on holiday travel?
- Elevate Your Wardrobe With the Top 11 Trending Amazon Styles Right Now
- Chris Martin and Dakota Johnson's Love Story Is Some Fairytale Bliss
- Medical debt affects millions, and advocates push IRS, consumer agency for relief
- 'Malcolm in the Middle’ to return with new episodes featuring Frankie Muniz
- Inside Clean Energy: What Lauren Boebert Gets Wrong About Pueblo and Paris
Ranking
- Working Well: When holidays present rude customers, taking breaks and the high road preserve peace
- And Just Like That's Costume Designers Share the Only Style Rule they Follow
- Fox News stands in legal peril. It says defamation loss would harm all media
- As a Senate Candidate, Mehmet Oz Supports Fracking. But as a Celebrity Doctor, He Raised Significant Concerns
- Cincinnati Bengals quarterback Joe Burrow owns a $3 million Batmobile Tumbler
- Biden Administration Unveils Plan to Protect Workers and Communities from Extreme Heat
- Consent farms enabled billions of illegal robocalls, feds say
- Does the 'Bold Glamour' filter push unrealistic beauty standards? TikTokkers think so
Recommendation
Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
How a civil war erupted at Fox News after the 2020 election
Colorado’s Suburban Firestorm Shows the Threat of Climate-Driven Wildfires is Moving Into Unusual Seasons and Landscapes
Shop J.Crew’s Extra 50% Off Sale and Get a $100 Skirt for $16, a $230 Pair of Heels for $28, and More
Skins Game to make return to Thanksgiving week with a modern look
While The Fate Of The CFPB Is In Limbo, The Agency Is Cracking Down On Junk Fees
Accused Pentagon leaker appeals pretrial detention order, citing Trump's release
FDA has new leverage over companies looking for a quicker drug approval